China spares no efforts to ensure anti-COVID drug production, supply

**This is a 60-seconds sample of the video. For the full version, please contact us.**

China spares no efforts to ensure anti-COVID drug production, supply

STORY: China spares no efforts to ensure anti-COVID drug production, supply DATELINE: Jan. 9, 2023 LENGTH: 00:02:09 LOCATION: Beijing CATEGORY: HEALTH SHOTLIST: 1. various of production lines 2. SOUNDBITE 1 (Chinese): YU XUEGANG, Ningxia Qiyuan Pharmaceutical Co., Ltd. 3. various of pharma firms speeding up anti-epidemic medicine production 4. SOUNDBITE 2 (Chinese): LI ZHILONG, Sinopharm Holding Ningxia Co., Ltd. 5. various of Luanzhen township hospital 6. SOUNDBITE 3 (Chinese): QIAO NAN, Director of medicine purchasing department of Luanzhen township hospital, Shaanxi 7. various of the local officials and staff working 8. various of the distribution of the health packages 9. SOUNDBITE 4 (Chinese): YAN CHENGWEI, Chongqing resident STORYLINE: China is implementing swift and concrete measures to accelerate drug development, production and supply, in order to guarantee better treatment of COVID-19 cases, as the country adjusts its epidemic response policy. Targeting classic symptoms of the infection, China h

  • Product Code
  • ILEA001224510
  • Registered date
  • 2023/1/09 00:00:00
  • Credit
  • Xinhua / Kyodo News Images
  • Media source
  • Xinhua News Agency.All Rights Reserved
  • Media size
  • 1920 × 1080 pixel
  • Deployment size
  • 137.02(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos